Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 3
2008 1
2009 1
2010 2
2011 2
2013 1
2014 2
2015 2
2016 5
2017 7
2018 3
2019 4
2020 1
2021 8
2022 11
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
Krasemann S, Haferkamp U, Pfefferle S, Woo MS, Heinrich F, Schweizer M, Appelt-Menzel A, Cubukova A, Barenberg J, Leu J, Hartmann K, Thies E, Littau JL, Sepulveda-Falla D, Zhang L, Ton K, Liang Y, Matschke J, Ricklefs F, Sauvigny T, Sperhake J, Fitzek A, Gerhartl A, Brachner A, Geiger N, König EM, Bodem J, Franzenburg S, Franke A, Moese S, Müller FJ, Geisslinger G, Claussen C, Kannt A, Zaliani A, Gribbon P, Ondruschka B, Neuhaus W, Friese MA, Glatzel M, Pless O. Krasemann S, et al. Among authors: gribbon p. Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20. Stem Cell Reports. 2022. PMID: 35063125 Free PMC article.
ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1.
Sharifi MA, Wierer M, Dang TA, Milic J, Moggio A, Sachs N, von Scheidt M, Hinterdobler J, Müller P, Werner J, Stiller B, Aherrahrou Z, Erdmann J, Zaliani A, Graettinger M, Reinshagen J, Gul S, Gribbon P, Maegdefessel L, Bernhagen J, Sager HB, Mann M, Schunkert H, Kessler T. Sharifi MA, et al. Among authors: gribbon p. Circ Res. 2023 Sep 29;133(8):674-686. doi: 10.1161/CIRCRESAHA.123.322737. Epub 2023 Sep 7. Circ Res. 2023. PMID: 37675562 Free PMC article.
Risk mitigation in academic drug discovery.
Ellinger B, Gribbon P. Ellinger B, et al. Among authors: gribbon p. Expert Opin Drug Discov. 2016;11(4):333-6. doi: 10.1517/17460441.2016.1152257. Epub 2016 Mar 3. Expert Opin Drug Discov. 2016. PMID: 26894865 No abstract available.
Validation of TREK1 ion channel activators as an immunomodulatory and neuroprotective strategy in neuroinflammation.
Schroeter CB, Nelke C, Schewe M, Spohler L, Herrmann AM, Müntefering T, Huntemann N, Kuzikov M, Gribbon P, Albrecht S, Bock S, Hundehege P, Neelsen LC, Baukrowitz T, Seebohm G, Wünsch B, Bittner S, Ruck T, Budde T, Meuth SG. Schroeter CB, et al. Among authors: gribbon p. Biol Chem. 2023 Feb 14;404(4):355-375. doi: 10.1515/hsz-2022-0266. Print 2023 Mar 28. Biol Chem. 2023. PMID: 36774650 Free article.
Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
Alharbi E, Gadiya Y, Henderson D, Zaliani A, Delfin-Rossaro A, Cambon-Thomsen A, Kohler M, Witt G, Welter D, Juty N, Jay C, Engkvist O, Goble C, Reilly DS, Satagopam V, Ioannidis V, Gu W, Gribbon P. Alharbi E, et al. Among authors: gribbon p. Drug Discov Today. 2022 Aug;27(8):2080-2085. doi: 10.1016/j.drudis.2022.05.010. Epub 2022 May 17. Drug Discov Today. 2022. PMID: 35595012 Free PMC article. Review.
Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents.
Arrazuria R, Kerscher B, Huber KE, Hoover JL, Lundberg CV, Hansen JU, Sordello S, Renard S, Aranzana-Climent V, Hughes D, Gribbon P, Friberg LE, Bekeredjian-Ding I. Arrazuria R, et al. Among authors: gribbon p. Front Microbiol. 2022 Sep 8;13:988728. doi: 10.3389/fmicb.2022.988728. eCollection 2022. Front Microbiol. 2022. PMID: 36160241 Free PMC article. Review.
Towards a hit for every target.
Rees S, Gribbon P, Birmingham K, Janzen WP, Pairaudeau G. Rees S, et al. Among authors: gribbon p. Nat Rev Drug Discov. 2016 Jan;15(1):1-2. doi: 10.1038/nrd.2015.19. Epub 2015 Nov 20. Nat Rev Drug Discov. 2016. PMID: 26585534
Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system.
Reus P, Guthmann H, Uhlig N, Agbaria M, Issmail L, Eberlein V, Nordling-David MM, Jbara-Agbaria D, Ciesek S, Bojkova D, Cinatl J, Burger-Kentischer A, Rupp S, Zaliani A, Grunwald T, Gribbon P, Kannt A, Golomb G. Reus P, et al. Among authors: gribbon p. J Control Release. 2023 Dec;364:654-671. doi: 10.1016/j.jconrel.2023.10.050. Epub 2023 Nov 16. J Control Release. 2023. PMID: 37939853 Free article.
PEMT: a patent enrichment tool for drug discovery.
Gadiya Y, Zaliani A, Gribbon P, Hofmann-Apitius M. Gadiya Y, et al. Among authors: gribbon p. Bioinformatics. 2023 Jan 1;39(1):btac716. doi: 10.1093/bioinformatics/btac716. Bioinformatics. 2023. PMID: 36322820 Free PMC article.
64 results